-
Diagnostics World | AI-driven diagnostics for gastroenterology, live-cell super-resolution microscopy, AI-based risk stratification for breast and prostate cancer, and more.
Feb 8, 2022
-
Diagnostics World | The healthcare industry not only appears ready for AI, some of its most digitally progressive players are already actively embracing it. These early use cases have begun to hint at AI’s potential value to healthcare providers, for its ability to provide an elevated level of data intelligence that could significantly improve patient outcomes and the overall patient experience, and on the business side, for its ability to improve efficiency and innovation.
Feb 3, 2022
-
Diagnostics World News | Skin health, single-cell spatial genomics, diabetic kidney disease, MS biomarkers, lung and colorectal cancer screening. Plus: home testing of peripheral neuropathies, new COVID tests, and more.
Feb 2, 2022
-
Diagnostics World News | Elaine Gee is Principal Data Scientist at Mirvie, a company dedicated to using technology to improve maternal health and identify pregnancy complications early using blood-based RNA profiling.
Jan 28, 2022
-
Diagnostics World News | Researchers at Mount Sinai and the University of Colorado are pursuing the possibilities that stem from predicting which COVID-19 patients are most likely to deteriorate over time. The hope is that this ability could help health care professionals more effectively triage patients and pair them with appropriate treatments to improve outcomes.
Jan 27, 2022
-
Diagnostics World News | It has proven exceedingly difficult to identify reliable and reproducible genetic markers for depression, but it now appears possible to efficiently leverage a biochemical hallmark to create a blood test. The basis of the test is the four-decade-old discovery that depression is tied to low levels of the intracellular molecule adenylyl cyclase, made in response to neurotransmitters such as serotonin and epinephrine.
Jan 25, 2022
-
Diagnostics World | Researchers at the University of Michigan (U-M) have made the connection between cellular motility—with a known connection to tumor metastasis—and the shape-shifting behavior of cancer cells to become more “missile-like” and thus better able to make the voyage from one site in the body to another. The newly acquired characteristic arises when epithelial cells morph into mesenchymal cells, but the transition can’t be seen if the cells are all held hostage on a glass microscope slide.
Jan 19, 2022
-
Diagnostics World News | At the JP Morgan Healthcare Conference—being held virtually again this year—diagnostics companies gave overviews of their 2021 business and their views of the future. Here are the highlights we noted from presentations from Thermo Fisher Scientific, Abbott, and Natera.
Jan 17, 2022
-
Diagnostics World News | Mammography has a lot of well-recognized shortcomings among women with dense breasts as well as those diagnosed with breast cancer who need their response to therapy closely monitored. A cheaper, noninvasive, and easy-to-perform test is now under development that could solve for its clinical limitations and is on track to hit the market as early as 2023.
Jan 13, 2022
-
Diagnostics World | Speaking at the 2022 JP Morgan Healthcare Conference—being held virtually again this year—deSouza, the CEO of Illumina, outlined the sequencing giant’s plans for expanding their diagnostic capabilities and business.
Jan 11, 2022
-
Diagnostics World News | We spoke with the vendor community of Diagnostics World to gather predictions for the coming year. They gave us additional forecasts for imaging data infrastructures, staffing shortage remedies, SaaS medical devices, avoiding bias in AI algorithms, and more.
Jan 10, 2022
-
Diagnostics World News | Researchers in Australia have succeeded in building a chemically induced dimerization (CID) system that can detect the concentration of the antimetabolite drug methotrexate in serum. Coupled with a functionally related biosensor of rapamycin, commonly used to prevent organ transplant rejection, they also looked at lab prototypes of a multiplexed bioelectronic system for repeated measurements of multiple analytes.
Jan 6, 2022
-
Diagnostics World | A global collaborative of researchers has used a novel platform based on cell-free RNA (cfRNA) to monitor patterns of gene expression as pregnancy progresses—including, surprisingly, genes that appear to originate with the developing fetus. They recently demonstrated the platform’s potential as a pregnancy screening tool, using preeclampsia as a test case, but it might logically also be brought to bear in the future treatment and prevention of any number of pregnancy-related complications.
Jan 5, 2022
-
Diagnostics World | Researchers in China have developed a noninvasive skin cholesterol detection system that could be useful in the long-term lipid management of cardiovascular diseases, meeting a critical unmet need.
Jan 4, 2022
-
Diagnostics World News | Technologies for blood collection and testing, immune-competent organoids, flow cytometry for cell therapies, and SPR-based proteomics
Dec 28, 2021
-
Diagnostics World News | With vaccines becoming widely available, there was still a need to expand testing capabilities, bringing these efforts right into the home with over-the-counter tests and thinking outside of the box with cheap smell-based testing. We also learned more about the process for various tests and interventions to transition from EUA to full approval, or why they might be abandoned.
Dec 27, 2021
-
Diagnostics World | Diagnostics partnerships on scalp-sensing electrodes, AI-powered pathology, and devices in China. Plus new products from Leica Microsystems, Foundation Medicine, PerkinElmer, more.
Dec 22, 2021
-
Diagnostics World News | People with type 1 diabetes face unique challenges in managing their disease, including, for many decades, the need to review their blood sugar levels and adjust insulin dosing by hand. Creation of an artificial pancreas system connecting glucose sensors and insulin pumps introduced automation, the technology has not been routinely available. Online peer communities filled this gap by engineering sophisticated, do-it-yourself solutions.
Dec 21, 2021
-
Bio-IT World | A growing number of companies are endeavoring to replicate the success of gene sequencing juggernaut Illumina in the burgeoning field of proteomics. A top contender is Nautilus Biotechnology, which has spent the past few years drumming up excitement about the potential for comprehensively profiled proteins to make therapeutic and diagnostic development more effective and time efficient.
Dec 16, 2021
-
Diagnostics World News | Histopathology is destined to go through the same sort of digital transformation that occurred in the home entertainment industry with the wholesale switchover from in-person visits at Blockbuster stores to anytime movie availability from streaming service Netflix.
Dec 14, 2021